This evidence paired with our model's prediction of 18 and 28% reductions in dead nephrons in the SGLT2 and SGLT2/1 simulations, respectively, suggest key mechanisms of SGLT2 renoprotection in CKD is through both acute reduction in glomerular pressures and chronic structural protection of functional nephrons. This evidence concerns the gene SLC5A2 and chronic kidney disease.